144 related articles for article (PubMed ID: 38888644)
21. Unexpected gaps in knowledge of familial hypercholesterolaemia among Dutch general practitioners.
Ibrahim S; de Goeij JN; Nurmohamed NS; Pang J; van den Bosch SE; Martens FMAC; Roeters van Lennep JE; Corpeleijn W; Tumkaya T; Hovingh GK; Watts GF; Stroes ESG; Reeskamp LF
Neth Heart J; 2024 May; 32(5):213-220. PubMed ID: 38573436
[TBL] [Abstract][Full Text] [Related]
22. Past, Present, and Future of Familial Hypercholesterolemia Management.
Rocha VZ; Santos RD
Methodist Debakey Cardiovasc J; 2021; 17(4):28-35. PubMed ID: 34824679
[TBL] [Abstract][Full Text] [Related]
23. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease.
Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
Circ J; 2017 Dec; 82(1):218-223. PubMed ID: 28701632
[TBL] [Abstract][Full Text] [Related]
24. Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia.
Agarwala A; Deych E; Jones LK; Sturm AC; Aspry K; Ahmad Z; Ballantyne CM; Goldberg AC
J Clin Lipidol; 2023; 17(1):150-156. PubMed ID: 36470719
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
[TBL] [Abstract][Full Text] [Related]
26. Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society.
Funabashi S; Kataoka Y; Hori M; Ogura M; Nakaoku Y; Nishimura K; Doi T; Nishikawa R; Tsuda K; Noguchi T; Harada-Shiba M
JACC Asia; 2021 Sep; 1(2):245-255. PubMed ID: 36338164
[TBL] [Abstract][Full Text] [Related]
27. The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia.
Pang J; Chan DC; Watts GF
Curr Atheroscler Rep; 2020 Sep; 22(11):64. PubMed ID: 32870376
[TBL] [Abstract][Full Text] [Related]
28. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Garoufi A; Lambadiari V; Dima I; Kiouri E; Agapakis D; Zacharis E; Antza C; Kolovou V; Koumaras C; Bantouvakis G; Liamis G; Liberopoulos EN
Endocrine; 2022 May; 76(2):324-330. PubMed ID: 35262845
[TBL] [Abstract][Full Text] [Related]
29. Familial hypercholesterolemia and cardiovascular disease in older individuals.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
[TBL] [Abstract][Full Text] [Related]
30. The tertiary hospital laboratory; a novel avenue of opportunistic screening of familial hypercholesterolemia.
Mirzaee S; Choy KW; Doery JCG; Zaman S; Cameron JD; Nasis A
Int J Cardiol Heart Vasc; 2019 Jun; 23():100354. PubMed ID: 31080874
[TBL] [Abstract][Full Text] [Related]
31. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
[TBL] [Abstract][Full Text] [Related]
33. Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics.
Chua YA; Nazli SA; Rosman A; Kasim SS; Ibrahim KS; Md Radzi AB; Mohd Kasim NA; Nawawi H
J Atheroscler Thromb; 2023 Oct; 30(10):1317-1326. PubMed ID: 36567112
[TBL] [Abstract][Full Text] [Related]
34. The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US.
Saadatagah S; Alhalabi L; Farwati M; Zordok M; Bhat A; Smith CY; Wood-Wentz CM; Bailey KR; Kullo IJ
Am J Prev Cardiol; 2022 Dec; 12():100393. PubMed ID: 36204653
[TBL] [Abstract][Full Text] [Related]
35. Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study.
Alonso R; Arroyo-Olivares R; Díaz-Díaz JL; Fuentes-Jiménez F; Arrieta F; de Andrés R; Gonzalez-Bustos P; Argueso R; Martin-Ordiales M; Martinez-Faedo C; Illán F; Saenz P; Donate JM; Sanchez Muñoz-Torrero JF; Martinez-Hervas S; Mata P
Atherosclerosis; 2024 Jun; 393():117516. PubMed ID: 38523000
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Hu P; Dharmayat KI; Stevens CAT; Sharabiani MTA; Jones RS; Watts GF; Genest J; Ray KK; Vallejo-Vaz AJ
Circulation; 2020 Jun; 141(22):1742-1759. PubMed ID: 32468833
[TBL] [Abstract][Full Text] [Related]
37. Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
Alhabib KF; Al-Rasadi K; Almigbal TH; Batais MA; Al-Zakwani I; Al-Allaf FA; Al-Waili K; Zadjali F; Alghamdi M; Alnouri F; Awan Z; Kinsara AJ; AlQudaimi A; Almahmeed W; Sabbour H; Traina M; Atallah B; Al-Jarallah M; AlSarraf A; AlSayed N; Amin H; Altaradi H
PLoS One; 2021; 16(6):e0251560. PubMed ID: 34086694
[TBL] [Abstract][Full Text] [Related]
38. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
39. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
